February 25, 2019 / 6:17 AM / a month ago

BRIEF-Spark Therapeutics To Be Acquired By Roche For $4.8 Bln

Feb 25 (Reuters) - Spark Therapeutics Inc:

* SPARK THERAPEUTICS ENTERS INTO DEFINITIVE MERGER AGREEMENT WITH ROCHE

* SPARK THERAPEUTICS INC - ROCHE TO ACQUIRE SPARK THERAPEUTICS FOR $114.50 PER SHARE REPRESENTING A TOTAL EQUITY VALUE OF $4.8 BILLION

* SPARK THERAPEUTICS INC - SPARK THERAPEUTICS WILL CONTINUE ITS OPERATIONS IN PHILADELPHIA AS AN INDEPENDENT COMPANY WITHIN ROCHE GROUP

* SPARK THERAPEUTICS INC - MERGER AGREEMENT HAS BEEN UNANIMOUSLY APPROVED BY BOARDS OF BOTH SPARK AND ROCHE

* SPARK THERAPEUTICS INC - ROCHE WILL PROMPTLY COMMENCE A TENDER OFFER TO ACQUIRE ALL OUTSTANDING SHARES OF SPARK'S STOCK Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below